Contact Us

PW Case Review Form
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


   * Please describe your case:

What injury have you suffered?

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Parker Waichman LLP Files Additional DePuy ASR Hip Implant Lawsuits

Apr 27, 2012 | Parker Waichman LLP

Parker Waichman LLP continues to file lawsuits on behalf of people injured by recalled metal-on-metal DePuy ASR hip implants.  The firm recently filed several new complaints, including one that claims a DePuy ASR hip implant caused a Virginia woman to suffer from elevated chromium and cobalt levels.

The plaintiff, a 62-year-old woman from Ferrum, Virginia, is seeking medical monitoring, as well as compensatory and punitive damages.  According to her complaint, she received a DePuy ASR Hip Implant on October 10, 2007. By February 2011, the Plaintiff was suffering from pain, as well as elevated chromium and cobalt levels due to her metal-on-metal DePuy ASR Hip Implant. 

Parker Waichman filed that lawsuit, and several others, on April 12, 2012, in the DePuy ASR hip implant multidistrict litigation currently underway in U.S. District Court, Northern District of Ohio.

More than 93,000 people worldwide had received a recalled DePuy ASR hip implant, according to a statement from Parker Waichman LLP. DePuy Orthopaedics, a division of Johnson & Johnson, issued a worldwide recall of the ASR Hip Resurfacing System and ASR Acetabular System in August 2012, after data from the National Joint Registry of England and Wales showed that 1 out of every 8 patients (12%-13%) who had received the devices had to undergo revision surgery within five years of receiving it.

Metal-on-metal hip implants have sparked concerns that they could be leaching dangerous amounts of metal ions into this tissue and blood streams of recipients.  This can lead to early failure of the implant, as well as damage to tissue and organs.  The U.S. Food & Drug Administration (FDA) had already directed 21 companies that market all-metal hip replacement to conduct post-market studies of their products to determine if they were shedding dangerous amounts of metallic debris in patients. It has also scheduled an advisory panel meeting for June to discuss the problems with metal-on-metal hip implants. The recommendations that come out of that meeting could lead to new testing standards and review requirements to be met before an all-metal hip implant device can be approved by the FDA.

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo